Strides Pharma sells majority stake in arm Pivot Path for Rs 100 crore
New Delhi, Strides Pharma Science Ltd on Saturday announced divestment of majority stake in its wholly-owned arm Pivot Path for Rs 100 crore to a consortium of investors led ...
- Latest
- Trending
